Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Challenges Ophthalmologists Face | OBN
We recently conducted a survey on LinkedIn to ask ophthalmologists about the largest problem they face in their field. A total of 153 people participated in the poll, and the results revealed some interesting insights. The top issue identified by…
Best 10 Mobile Apps for Eye Health
According to recent studies, 4.5 billion people worldwide suffer from some form of visual impairment. Fortunately, technology has come a long way in helping people manage and improve their eye health. From monitoring vision changes to providing personalized exercises and…
FDA Warns Regener-Eyes Over Unapproved Amniotic Eye Drops
The FDA has issued a warning letter to the Regenerative Processing Plant, manufacturer of Regener-Eyes Pro and Lite eye drops, for marketing unapproved products claiming to treat dry eyes. These products, which contain amniotic fluid, raise significant safety concerns. The…
MCG Secures $1.5M Grant for New Diabetic Retinopathy Therapy
Researchers at the Medical College of Georgia (MCG) at Augusta University have been awarded a $1.5 million grant from the National Eye Institute to develop a new treatment for diabetic retinopathy, a leading cause of blindness. Diabetic retinopathy results from…
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
Oculus has unveiled the Pentacam Cornea OCT, an innovative device that integrates Scheimpflug imaging with the world’s first pericentric OCT scanning system. This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the cornea in just one…
Dangers of Eye Color-Changing Drops: Ophthalmologists Warn
The American Academy of Ophthalmology is warning the public about over-the-counter eye drops that claim to change eye color. These products, popularized on social media platforms like TikTok, are unproven, unregulated, and could pose significant risks to eye health. Unapproved…
Opus Genetics Receives FDA RPD Designation for OPGx-LCA5
Research Triangle Park, N.C. – August 20, 2024 – Opus Genetics has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for its ocular gene therapy, OPGx-LCA5, which aims to treat patients with…
Sandoz Receives FDA Approval for ENZEEVU™
Sandoz has secured FDA approval for ENZEEVU™ (aflibercept-abzv), a biosimilar to EYLEA®, to treat retinal conditions like wet age-related macular degeneration (AMD) and diabetic retinopathy. This approval strengthens Sandoz’s U.S. biosimilar portfolio, offering a cost-effective alternative for managing retinal diseases.…
AMD Explained: Tips for Safeguarding Your Vision
The eyes are often called the windows to the soul, but what happens when those windows become cloudy and blurred? That’s the reality for millions suffering from age-related macular degeneration (AMD), which can rob you of your precious eyesight as…
Exclusive: Key Events at ESCRS 2024
The 42nd of the European Society of Cataract and Refractive Surgeons (ESCRS) is poised to offer a dynamic array of events and initiatives in 2024, featuring a mix of educational programs, commemorative milestones, and new insights into key areas of…